Publication | Open Access

A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery

Surgical OncologyCervical Cancer ManagementCervical CancerRadiation TherapyRadical SurgeryMedicineSingle-agent CisplatinSurgeryRadiotherapy Versus Docetaxel/cisplatinPublic HealthCancer TreatmentOncologyRadiation OncologyGynecology Oncology